Skip to main

Lung Disease and Transplant: General Information

A lung transplant is surgery that removes a patient’s unhealthy lung (or lungs) and replaces it with:

  • A healthy lung from a donor (usually deceased)
  • Part of a healthy lung (from a living donor)

Most patients replace both lungs in a transplant surgery (double lung transplant). Some patients have:

  • Surgery to replace only 1 lung (single lung transplant)
  • More than one lung transplant surgery

Usually, patients need a lung transplant if they have: 

  • Pulmonary fibrosis
  • Chronic obstructive pulmonary disease (COPD)
  • Cystic fibrosis
  • Pulmonary hypertension
  • A different disease that affects their lungs

Age guidelines

  • Anyone (newborn to adult) can have a lung transplant
  • Some guidelines say lung transplant patients should be younger than 65
  • Many patients over 65 do have lung transplants
  • Usually, patients over 75 do not qualify, but transplant centers make the final decisions

Lung Transplant Waitlist

A patient is put on the transplant waitlist when their transplant team decides they meet requirements for lung transplant.

The treatment team gives the patient a Lung Allocation Score (LAS) to predict how long the patient:

  • Can live without a lung transplant
  • Might live after lung transplant surgery

A higher LAS score means the patient is higher on the lung transplant waitlist, so they will get a lung transplant sooner. 

Learn more about LAS scores: 

Donor Lungs

Transplant centers use ex-vivo lung perfusion (EVLP) so they have more donor lungs they can use for transplant. 

EVLP is technology that circulates a solution (nutrients, proteins, and oxygen) through donor lungs to: 

  • Evaluate their health
  • Improve their health
  • Reverse lung damage

Ask your transplant team about donor lungs from increased-risk donors

  • Patients who accept organs from increased-risk donors usually wait less time for an organ
  • An increased-risk donor is a deceased donor with higher risk of spreading one of the following undiagnosed diseases to a transplant patient (Abara et al., 2019):
    • Human immunodeficiency virus (HIV)
    • Hepatitis B, or 
    • Hepatitis C (HCV)
  • Organs from increased-risk donors are not lower quality

Advertisements & Sponsors

This content was developed independently by AST and supported by a financial contribution from Sanofi